Testing effectiveness (Phase 2)Looking for participantsNCT05842785
What this trial is testing
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
Who this might be right for
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
Tyligand Bioscience (Shanghai) Limited 162